A mycotoxin degrading agent for animal feed and its preparation method

By constructing a nanogel network using polyphenol crosslinking agents and metal ion sources in feed, and encapsulating the enzyme complex with pH-responsive materials, the problem of enzyme activity loss during feed processing and storage was solved, achieving enzyme stability and efficient detoxification.

CN123100756APending Publication Date: 2026-11-17GUANGDONG SANXING BIOTECHNOLOGY CO LTD +1
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202611434841.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-16
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

In existing technologies, biological enzymes are easily inhibited by oils, organic acids and metal ions during feed processing and storage, resulting in enzyme activity loss and difficulty in adapting to the animal's gastrointestinal environment, leading to unstable detoxification effects.

Method used

A nanogel network was constructed using a polyphenol crosslinking agent and a metal ion source to immobilize a bioenzyme complex, which was then coated with a pH-responsive coating material to form a core-shell structure, thus protecting the enzyme complex and maintaining its activity in the gastrointestinal environment.

Benefits of technology

It significantly improves the heat and acid resistance of enzymes, ensuring that enzyme activity is not lost during processing and storage, and is precisely released in the intestinal environment, achieving efficient degradation of mycotoxins and improving the safety and stability of feed.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_5
    Figure SMS_5
  • Figure SMS_6
    Figure SMS_6
  • Figure SMS_7
    Figure SMS_7
Patent Text Reader

Abstract

This application discloses a mycotoxin degrading agent for animal feed and its preparation method. The raw materials, by weight, comprise the following components: 10-25 parts of a bio-enzyme complex; 2-8 parts of a coenzyme factor; 5-15 parts of a polyphenol cross-linking agent; 0.5-3 parts of a metal ion source; 20-40 parts of a pH-responsive coating material; 3-10 parts of a dispersing agent; and 20-75 parts of an inert filler carrier. The mycotoxin degrading agent in this solution employs a core-shell dual-protection structure, combining a polyphenol cross-linked core with a pH-responsive coating shell. On one hand, it cross-links and fixes the bio-enzyme complex and coenzyme factor, reducing enzyme activity loss during processing and storage, while simultaneously enhancing the synergistic effect between the bio-enzyme complex and coenzyme factor, thus improving the conversion efficiency of mycotoxin degradation. On the other hand, it relies on the pH-responsive shell to achieve targeted controlled release, preventing premature release of active components such as the bio-enzyme complex. This effectively solves the problems of low enzyme activity retention and unstable detoxification effects in existing enzyme preparations, ensuring feed safety and making it suitable for industrial application in the feed industry.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This application relates to the field of fine chemical technology, and in particular to a mycotoxin degrading agent for animal feed and its preparation method. Background Technology

[0002] Mycotoxin contamination is a major problem that urgently needs to be solved in the field of feed safety. Deoxynivalenol (DON), a trichothecene toxin, is highly hydrophilic and difficult to remove effectively using traditional physical adsorption methods. To overcome the limitations of physical adsorption technology, a scheme is proposed based on the existing patent US20230380451A1: a method that uses biological enzymes (e.g., aldehyde-ketone reductase) to catalytically convert deoxynivalenol (DON) into a low-toxicity derivative. This existing technology, by introducing a specific functional enzyme system, can achieve the biological detoxification of deoxynivalenol (DON) and improve the safety of feed products.

[0003] However, the above-mentioned enzymatic detoxification scheme lacks protection for the enzymes during implementation. Instead, the enzymes are directly added to the feed matrix and mixed. Since the oils, organic acids, and metal ions in the feed matrix can inhibit the enzymes, the enzymes are deactivated and lost during feed processing. At the same time, the feed mixed with enzymes cannot adapt to the differences between the storage environment and the animal's gastrointestinal environment, which can easily cause the active components of the enzymes to be released prematurely. This leads to technical problems such as low enzyme activity retention rate, poor batch stability, and difficulty in guaranteeing the detoxification effect. Summary of the Invention

[0004] This application aims to address at least one of the technical problems existing in the prior art. To this end, one objective of this application is to provide a mycotoxin degrading agent for animal feed and a method for preparing the same, which improves the uniformity of material structure, optimizes mechanical properties and oxygen permeability through a modular synergistic approach, and significantly enhances long-term stability and storage safety.

[0005] This application provides a mycotoxin degrading agent for animal feed, the raw materials of which comprise the following components by weight: 10-25 parts of bio-enzyme complex; 2-8 parts of coenzyme factor; 5-15 parts of polyphenol crosslinking agent; 0.5-3 parts of metal ion source; 20-40 parts of pH-responsive coating material; Dispersing agent 3-10 parts; 20-75 parts of inert filler carrier.

[0006] In any embodiment, the bioenzyme complex comprises aldehyde-ketone reductase and PQQ-dependent dehydrogenase; the mass ratio of aldehyde-ketone reductase to PQQ-dependent dehydrogenase is 2:1 to 3:1.

[0007] In any embodiment, the coenzyme factor comprises auto-oxidized coenzyme II and pyrroloquinoline quinone; the mass ratio of the oxidized coenzyme II to pyrroloquinoline quinone is 1:4 to 1:6.

[0008] In any embodiment, the polyphenolic crosslinking agent includes any one or a mixture of two or more of tannic acid, gallic acid, and tea polyphenols.

[0009] In any embodiment, the metal ion source includes any one or a mixture of two or more of ferric chloride, zinc sulfate, and calcium chloride.

[0010] In any embodiment, the pH-responsive coating material comprises any one of methacrylate-ethyl acrylate copolymer, hydroxypropyl methylcellulose phthalate, and polyacrylic acid resin II.

[0011] This application provides a method for preparing the above-mentioned mycotoxin degrading agent for animal feed, comprising the following steps: S1. Dissolve the biological enzyme complex and coenzyme factor in a buffer solution, add a polyphenol cross-linking agent, stir and mix evenly to obtain an initial mixture for later use; S2. Add metal ion source solution dropwise to the initial mixture in step S1, while controlling the reaction temperature at 20-35℃ and the reaction time at 1-3 hours. After the initial mixture forms a precipitate, collect it by centrifugation to obtain the kernel precursor for later use. S3. Take the core precursor obtained in step S2 and put it into a fluidized bed. Spray the pH-responsive coating material solution continuously through an atomizing nozzle to coat the surface of the core precursor particles to obtain pre-coated microcapsules for later use. The fluidized bed inlet temperature is 50-70℃, the outlet temperature is 35-45℃, and the fluidized bed temperature is not higher than 42℃.

[0012] S4. Take the pre-coated microcapsules from step S3, and dry mix them with the dispersant and inert filler carrier to obtain the finished product of mycotoxin degrading agent for animal feed.

[0013] In any embodiment, the pH value of the buffer solution in step S1 is 6.8-7.5; the stirring rate is 200-450 rpm; and the stirring time is 20-50 minutes.

[0014] In any embodiment, the mixing speed of the dry mix in step S4 is 20-50 rpm; the mixing time is 15-30 minutes.

[0015] This application provides, in three aspects, the use of the aforementioned mycotoxin degrading agent in the preparation of animal feed.

[0016] The beneficial effects of the embodiments of the present invention are as follows: The mycotoxin degrading agent provided in this application adopts a core-shell dual protection structure with a polyphenol cross-linked core and a pH-responsive outer shell. On the one hand, it cross-links and fixes the bio-enzyme complex and coenzyme factors to resist the inhibition and damage of oils, organic acids, and metal ions in the feed matrix, reducing enzyme activity loss during processing and storage. At the same time, it enhances the synergistic effect of the bio-enzyme complex and coenzyme factors, improving the conversion efficiency of mycotoxin degradation. On the other hand, it relies on the pH-responsive shell to achieve targeted controlled release, avoiding premature release of active components such as the bio-enzyme complex, and ensuring that the bio-enzyme complex is released and takes effect at the target site in the animal intestine. It effectively solves the problems of low enzyme activity retention and unstable detoxification effect of existing enzyme preparations, ensuring feed safety and making it suitable for industrial application in the feed industry. Detailed Implementation

[0017] Hereinafter, embodiments of the present application are disclosed in detail with appropriate reference to the detailed description. However, unnecessary detailed descriptions may be omitted. For example, detailed descriptions of well-known matters and repetitive descriptions of actually identical structures may be omitted. This is to avoid making the following description unnecessarily lengthy and to facilitate understanding by those skilled in the art. Furthermore, the following description is provided to enable those skilled in the art to fully understand the present application and is not intended to limit the subject matter of the claims.

[0018] The "range" disclosed in this application is defined by a lower limit and an upper limit. A given range is defined by selecting a lower limit and an upper limit, which define the boundaries of a particular range. Ranges defined in this way can include or exclude endpoints and can be arbitrarily combined; that is, any lower limit can be combined with any upper limit to form a range. For example, if ranges of 60-120 and 80-110 are listed for a specific parameter, it is expected that ranges of 60-110 and 80-120 are also included. Furthermore, if minimum range values ​​of 1 and 2 are listed, and if maximum range values ​​of 3, 4, and 5 are listed, then the following ranges are all expected: 1-3, 1-4, 1-5, 2-3, 2-4, and 2-5. In this application, unless otherwise stated, the numerical range "ab" represents a shortened representation of any combination of real numbers between a and b, where a and b are real numbers. For example, the numerical range "0-5" indicates that all real numbers between "0-5" have been listed in this article; "0-5" is simply a shortened representation of these numerical combinations. Furthermore, when a parameter is stated as an integer ≥2, it is equivalent to disclosing that the parameter is, for example, an integer such as 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, etc.

[0019] Unless otherwise specified, all embodiments and optional embodiments of this application can be combined to form new technical solutions.

[0020] Unless otherwise specified, all technical features and optional technical features of this application may be combined to form new technical solutions.

[0021] Unless otherwise specified, all steps in this application may be performed sequentially or randomly, preferably sequentially. For example, the method includes steps (a) and (b), indicating that the method may include steps (a) and (b) performed sequentially, or it may include steps (b) and (a) performed sequentially. For example, the mention that the method may also include step (c) indicates that step (c) may be added to the method in any order. For example, the method may include steps (a), (b), and (c), or it may include steps (a), (c), and (b), or it may include steps (c), (a), and (b), etc.

[0022] Unless otherwise specified, the terms "comprising" and "including" as used in this application can be open-ended or closed-ended. For example, "comprising" and "including" can mean that other components not listed may also be included, or that only the listed components may be included.

[0023] Unless otherwise specified, the term "or" is inclusive in this application. For example, the phrase "A or B" means "A, B, or both A and B". More specifically, the condition "A or B" is satisfied by any of the following conditions: A is true (or exists) and B is false (or does not exist); A is false (or does not exist) and B is true (or exists); or both A and B are true (or exist).

[0024] Mycotoxin degrading agents for animal feed As used in this article, "mycotoxin degrading agent" is a type of feed additive. Deoxynivalenol (DON, vomitoxin), a member of the trichothecenes family, is highly hydrophilic, and common montmorillonite-based physical adsorbents have limited effect on it. This product, through specific degrading enzymes or functional microorganisms, destroys the toxic structures of toxins such as DON, zearalenone, and aflatoxin, decomposing them into non-toxic products, thus reducing toxic reactions such as intestinal damage, decreased feed intake, and immunosuppression in animals. This product cannot kill molds, nor can it prevent further toxin production in feed. It cannot replace high-quality raw materials and proper storage management, and is suitable for use in livestock such as pigs and poultry.

[0025] This article provides a mycotoxin degrading agent for animal feed, the raw materials of which contain the following components by weight: 10-25 parts of bio-enzyme complex; 2-8 parts of coenzyme factor; 5-15 parts of polyphenol crosslinking agent; 0.5-3 parts of metal ion source; 20-40 parts of pH-responsive coating material; Dispersing agent 3-10 parts; 20-75 parts of inert filler carrier.

[0026] Existing technologies typically involve directly spraying enzyme preparations onto a carrier surface. However, this application utilizes polyphenol crosslinking agents and metal ion sources to construct a coordination network in situ, tightly locking the bio-enzyme complex and coenzyme factors within a nanoscale gel network. This strategy of co-immobilizing the bio-enzyme complex and coenzyme factors not only prevents coenzyme loss during storage but also significantly improves heat and acid resistance by rigidly confining the thermal motion of enzyme protein molecules through the coordination bonds. Simultaneously, the outer pH-responsive coating material utilizes specific polymers that maintain a dense structure in acidic or neutral environments while rapidly dissolving and releasing the core in the weakly alkaline intestinal environment, achieving precise spatiotemporal control.

[0027] In a preferred embodiment, the bioenzyme complex comprises aldehyde-ketone reductase and PQQ-dependent dehydrogenase; the mass ratio of aldehyde-ketone reductase to PQQ-dependent dehydrogenase is 2:1 to 3:1.

[0028] Specifically, the bioenzyme complex is composed of aldehyde-ketone reductase and PQQ-dependent dehydrogenase. The PQQ-dependent dehydrogenase, with pyrroloquinoline quinone (PQQ) as a coenzyme, can oxidize the C3 hydroxyl group of deoxynivalenol (DON) to generate the intermediate product 3-keto-DON. The aldehyde-ketone reductase further stereoselectively reduces 3-keto-DON to non-toxic 3-epio-DON. The two work together to achieve enzymatic detoxification of DON.

[0029] In a preferred embodiment, the coenzyme factor includes auto-oxidized coenzyme II and pyrroloquinoline quinone; the mass ratio of the oxidized coenzyme II to pyrroloquinoline quinone is 1:4 to 1:6.

[0030] Specifically, the coenzyme factor comprises pyrroloquinoline quinone and auto-oxidative coenzyme II; which are respectively PQQ Dependent dehydrogenases and aldehyde-ketone reductases provide the necessary redox cofactors for catalysis, ensuring the smooth progress of the two-step enzymatic reaction.

[0031] In a preferred embodiment, the polyphenol crosslinking agent includes any one or a mixture of two or more of tannic acid, gallic acid, and tea polyphenols.

[0032] Specifically, the molecular structure of the aforementioned polyphenol crosslinking agent is rich in a large number of ortho-phenolic hydroxyl groups. By utilizing the coordination and chelation between the phenolic hydroxyl groups and the metal ions dissociated from the metal ion source, a polyphenol-metal ion coordination crosslinking network is constructed, which serves as a crosslinking node to modify the pH-responsive coating substrate.

[0033] The beneficial effects are as follows: First, by coordinating crosslinking, the density and mechanical strength of the coating material are improved, which inhibits the premature swelling and rupture of the coating material in the acidic environment of the stomach and reduces the degradation and inactivation of the internal biological enzyme complex by gastric acid. Next, tannic acid, gallic acid, and tea polyphenols are all polyhydroxy natural polyphenols. The raw materials are readily available, have good compatibility, will not introduce highly toxic impurities, and meet the safety requirements of feed additives. Finally, when multiple polyphenols are used in combination, the cross-linking density can be synergistically controlled to avoid the defects of excessive cross-linking that makes the membrane difficult to dissociate, or insufficient cross-linking that results in low membrane strength, thus balancing the coating protection effect and intestinal release performance.

[0034] In a preferred embodiment, the metal ion source includes any one or a mixture of two or more of ferric chloride, zinc sulfate, and calcium chloride.

[0035] Specifically, the aforementioned metal salts can dissociate into corresponding metal cations, which can undergo coordination chelation reactions with the phenolic hydroxyl groups of polyphenol crosslinking agents, acting as crosslinking centers and participating in the construction of a polyphenol-metal ion coordination crosslinking network.

[0036] The beneficial effects are as follows: First, the metal ions generated by dissociation synergistically with polyphenols can regulate the cross-linking density of the coating membrane, thereby improving the mechanical strength and acid resistance of the membrane. Second, iron, zinc, and calcium are all mineral elements required by animal bodies, and the small amount of dissolution from the system will not pose a risk to feed safety, meeting the safety requirements for feed products. Third, the above-mentioned metal salt powders are easy to disperse and have good compatibility with other powder components, making them less prone to local agglomeration and clumping. Finally, the combined use of multiple metal salts can flexibly adjust the strength of coordination cross-linking, avoiding excessive cross-linking caused by a single metal ion, which makes it difficult for the intestine to depolymerize and release enzymes, or insufficient cross-linking leading to coating protection failure, thus balancing the acid resistance of the coating and the efficiency of intestinal enzyme release.

[0037] In a preferred embodiment, the pH-responsive coating material includes any one of methacrylate-ethyl acrylate copolymer, hydroxypropyl methylcellulose phthalate, and polyacrylic acid resin II.

[0038] Specifically, methacrylic acid Ethyl acrylate copolymer: This material exhibits high film flexibility, uniform and dense film layer, and excellent acid resistance. It remains structurally stable, does not swell or crack, even in the highly acidic environment of the stomach (pH < 5.0). It effectively isolates aldehyde and ketone reductases and PQQ from gastric acid and proteases. It inactivates and destroys dependent dehydrogenases; it rapidly ionizes and dissolves in the intestinal neutral environment with pH ≥ 5.5, stably releasing enzyme activity. Simultaneously, this material has low impurity content, high biocompatibility, tolerates short-term high temperatures during feed pelleting, and exhibits strong film-forming stability, effectively improving the storage stability of coated pellets.

[0039] Hydroxypropyl methylcellulose phthalate (HPMCP) is a cellulose-based enteric-coated material with excellent film-forming properties. It can be molded without large amounts of plasticizers, resulting in membranes with good toughness and resistance to brittleness. This material has a precise dissolution response threshold, rapidly dissolving and releasing enzymes in the weakly acidic environment of the small intestine. This results in rapid drug release and timely onset of action, avoiding the reduced toxin degradation efficiency caused by delayed enzyme release. Furthermore, it exhibits excellent compatibility with polyphenol and metal ion crosslinking systems, significantly improving the overall density and impermeability of composite coated membranes.

[0040] Polyacrylic acid resin II is a classic anionic enteric-coated resin with stable pH response. It is completely insoluble in the acidic environment of gastric juice but rapidly dissolves and dehydrates enzymes in the intestinal environment at pH 6.0–6.5. This material exhibits good powder dispersibility and strong process adaptability, making it suitable for powder particle coating processing and ensuring high consistency in mass production. Used alone, it provides basic enteric protection. When combined with two other materials, it allows for precise control of the crosslinking density and dissolution rate of the coating film, compensating for the shortcomings of single-material films such as excessive brittleness, slow drug release, or insufficient acid resistance.

[0041] The beneficial effects are as follows: the combination of the above three materials can complement each other, constructing a gradient pH-responsive composite membrane structure, and combining polyphenols. Metal ion cross-linking modification significantly improves the coating system's resistance to gastric acid, granulation heat resistance, and intestinal controlled-release enzyme performance, maximizing the retention of complex enzyme activity and ensuring the efficient degradation of DON mycotoxins, while meeting the requirements for safe, stable, and residue-free use of feed additives.

[0042] In a preferred embodiment, the dispersing agent includes one or more of silica, magnesium stearate, and microcrystalline cellulose, or a mixture thereof.

[0043] Specifically, the aforementioned dispersing agents are used to improve the flowability, dispersion uniformity, and formability of the various powder raw materials in the system, and to solve the problems of easy agglomeration, stratification, and uneven mixing of biological enzymes, polyphenol crosslinking agents, metal salts, and coated powders, thereby ensuring uniform structure and stable performance of the coated particles.

[0044] In a preferred embodiment, the inert filling carrier is selected from one or more of zeolite powder, diatomaceous earth, and light calcium carbonate, or a mixture thereof.

[0045] Specifically, it is used to supplement the quality of the system, improve the processing properties of powder, is chemically inert, does not interfere with the enzymatic reaction and the polyphenol-metal ion coordination crosslinking process, and meets the safety requirements for feed use.

[0046] In a preferred embodiment, the cumulative release rate of the mycotoxin degrading agent's shell is less than 5% at pH 1.2 and greater than 80% within 2 hours at pH 6.8.

[0047] In a preferred embodiment, the mycotoxin degrading agent is used in the preparation of animal feed.

[0048]

Preparation Method

[0049] S4. Take the pre-coated microcapsules from step S3, and dry mix them with the dispersant and inert filler carrier to obtain the finished product of mycotoxin degrading agent for animal feed.

[0050] In a preferred embodiment, the pH value of the buffer solution in step S1 is 6.8-7.5; the stirring rate is 200-450 rpm; and the stirring time is 20-50 minutes.

[0051] In a preferred embodiment, the metal ion source solution is added in step S2 over a period of 30-60 minutes, and the temperature for the reaction is controlled at 20-35°C after the addition is complete.

[0052] In a preferred embodiment, the atomization pressure of the atomizing nozzle in step S2 is controlled at 0.2-0.4 MPa.

[0053] In a preferred embodiment, the mixing speed of the dry mix in step S4 is 20-50 rpm; the mixing time is 15-30 minutes.

[0054] This application provides a preparation process for the aforementioned degradative agent. The innovation of this process lies in the optimization of parameter configuration and the design of the technical route. Traditional immobilization processes often involve harsh chemical cross-linking conditions, which can easily damage the enzyme's active site. This application employs a mild self-assembly strategy, completing the formation of the coordination network within a low-temperature range of 20-35℃, maximizing the preservation of the natural conformation of the biological enzyme. Furthermore, the temperature parameters for spray drying or fluidized bed coating are carefully selected, with the inlet air temperature controlled between 80-120℃, ensuring both the film-forming quality of the coating material and avoiding irreversible damage to the core enzyme activity caused by high temperatures. This stepwise construction and mild curing technical route ensures a high retention rate of effective enzyme activity in the final product.

[0055] [Implementation process of the examples and comparative examples] The following describes embodiments of this application. The embodiments described below are exemplary and are only used to explain this application, and should not be construed as limiting this application. Where specific techniques or conditions are not specified in the embodiments, they are performed according to the techniques or conditions described in the literature in this field or according to the product instructions. Reagents or instruments used, unless otherwise specified, are all conventional products that can be obtained commercially.

[0056] Example 1 The raw materials for mycotoxin degrading agents for animal feed are as follows, in parts by weight:

[0057] The specific preparation method is as follows: S1: Dissolve 18 parts of the biological enzyme complex (aldol reductase: 12 parts; PQQ-dependent dehydrogenase: 6 parts) and 5 parts of coenzyme factor (oxidized coenzyme II: 2.5 parts; pyrroloquinoline quinone: 2.5 parts) completely in phosphate buffer with a pH of 7.0. Stir at 300 rpm, then add 10 parts of tannic acid and continue stirring for 30 minutes until the mixture is homogeneous, to obtain a clear and transparent mixture A. S2: Dissolve 1.6 parts of ferric chloride in deionized water to prepare a metal ion source solution. Under the condition of a water bath at 30°C, slowly add the solution dropwise to the mixture A. The dropwise addition time is controlled at 45 minutes. After the dropwise addition is completed, continue to react at 30°C for 2 hours to form a dark brown "enzyme-coenzyme-polyphenol metal" coordination nanogel precipitate. Then, centrifuge at 4000 rpm to collect the precipitate and wash it three times with deionized water to remove unreacted free ions to obtain the core precursor. S3: Take the core precursor obtained in step S2 and put it into a fluidized bed device. Then, continuously spray 30 parts of methacrylic acid-ethyl acrylate copolymer solution through an atomizing nozzle to coat the surface of the core precursor particles to obtain pre-coated microcapsules for later use. The fluidized bed inlet temperature is 60°C, the outlet temperature is 40°C, and the bed material temperature is 38°C. S4: The pre-coated microcapsules obtained in step S3 are added together with 6 parts of silica and 34.4 parts of zeolite powder into a three-dimensional motion mixer. The mixing speed is set to 35 rpm and the mixing time is 23 minutes until the material has a uniform color, thus obtaining the finished product of the mycotoxin degrading agent for animal feed.

[0058] Example 2 Compared with Example 1, the difference lies in the adjustment of the bio-enzyme complex and the corresponding adjustment of the specific components of other formulations.

[0059] The raw materials for mycotoxin degrading agents for animal feed are as follows, in parts by weight:

[0060] Example 3 Compared with Example 1, the difference lies in adjusting the specific components of the polyphenol crosslinking agent and the metal ion source, and adjusting the specific components of other formulation components accordingly.

[0061] The raw materials for mycotoxin degrading agents for animal feed are as follows, in parts by weight:

[0062] Example 4 Compared with Example 1, the difference lies in adjusting the type and amount of pH-responsive coating material, and making corresponding adjustments to the specific components of other formulations.

[0063] The raw materials for mycotoxin degrading agents for animal feed are as follows, in parts by weight:

[0064] Example 5 Compared with Example 1, the difference lies in adjusting the amount of biological enzymes and coenzyme factors, and making corresponding adjustments to the specific components of other formulations.

[0065] The raw materials for mycotoxin degrading agents for animal feed are as follows, in parts by weight:

[0066] Example 6 Compared with Example 1, the difference is that the metal ion source is changed to calcium chloride, and the specific components of other formulations are adjusted accordingly.

[0067] The raw materials for mycotoxin degrading agents for animal feed are as follows, in parts by weight:

[0068] Example 7 Compared with Example 1, the difference lies in the adjustment of the bio-enzyme complex and the corresponding adjustment of the specific components of other formulations.

[0069] The raw materials for mycotoxin degrading agents for animal feed are as follows, in parts by weight:

[0070] Example 8 The only difference from Example 1 is that the type and amount of pH-responsive coating material are adjusted, and the specific components of other formulations are adjusted accordingly.

[0071] The raw materials for mycotoxin degrading agents for animal feed are as follows, in parts by weight:

[0072] Example 9 The only difference from Example 1 is that the type and amount of metal ion source are adjusted, and the specific components of other formulations are adjusted accordingly.

[0073] The raw materials for mycotoxin degrading agents for animal feed are as follows, in parts by weight:

[0074] Comparative Example 1 The only difference from Example 1 is that the polyphenol crosslinking agent is omitted; all other components and processes are the same as in Example 1. The raw materials for mycotoxin degrading agents for animal feed are as follows, in parts by weight:

[0075] Comparative Example 2 The only difference from Example 1 is that the metal ion source is omitted; all other components and processes are the same as in Example 1. The raw materials for mycotoxin degrading agents for animal feed are as follows, in parts by weight:

[0076] Comparative Example 3 The only difference from Example 1 is that the pH-responsive coating material is omitted; all other components and processes are the same as in Example 1.

[0077] The raw materials for mycotoxin degrading agents for animal feed are as follows, in parts by weight:

[0078] Comparative Example 4 The only difference from Example 1 is that the polyphenol crosslinking agent and metal ion source are omitted, while the other components and process flow are the same as in Example 1.

[0079] The raw materials for mycotoxin degrading agents for animal feed are as follows, in parts by weight:

[0080] Comparative Example 5 The only difference from Example 1 is that the core component ratio is outside the scope of this invention, while the other components and process flow are the same as in Example 1.

[0081] The raw materials for mycotoxin degrading agents for animal feed are as follows, in parts by weight:

[0082]

evaluate

[0083] Experimental data: Record the percentage of relative enzyme activity retention for each sample.

[0084] B: Targeted release characteristic test in a simulated gastrointestinal fluid environment Experimental participants: Examples 1-9, Comparative Examples 1-5; Experimental equipment: The intelligent dissolution tester, model RCZ-8M, was manufactured by Tianjin Tianda Tianfa Technology Co., Ltd. High performance liquid chromatograph, model L0100; Experimental methods: S1: Each sample was placed in a dissolution vessel containing 500 mL of simulated gastric juice (pH 1.2, containing pepsin), stirred at 37°C and 50 rpm for 2 hours, and samples were taken every 30 minutes to determine the concentration of the released enzyme protein and the DON degradation activity. S2: Transfer the above sample to a dissolution vessel containing 500 mL of simulated intestinal fluid (pH 6.8, containing pancreatic enzymes), and continue stirring at 37°C and 50 rpm for 4 hours. Take samples at the same intervals for determination. S3: Calculate the cumulative release rate during the SGF phase and the burst release rate within 2 hours during the SIF phase to evaluate its targeted release index.

[0085] Experimental data: Record the cumulative release rate of each sample during the SGF stage and the cumulative release rate after conversion to SIF.

[0086] C: Long-term storage stability and actual degradation efficiency of DON test Experimental participants: Examples 1-9, Comparative Examples 1-5; Experimental equipment: The constant temperature and humidity incubator, model LHS-150SC, was manufactured by Shanghai Yiheng Scientific Instruments Co., Ltd. The rapid mycotoxin test strip is model Raptor and manufactured by CharmSciences. Experimental methods: S1: Store each sample in a constant temperature and humidity chamber at 40℃ and 75% relative humidity for 90 days to simulate a long shelf life; S2: Take the stored sample and add it to artificially contaminated corn and soybean meal-based basic feed at an addition rate of 0.1% (initial DON concentration is 2.0 mg / kg). S3: The mixed feed was incubated at 37°C and 60% humidity for 24 hours to simulate the internal environment of the animal after feeding. Then the residual concentration of DON in the feed was measured and the degradation rate was calculated.

[0087] Experimental data: Record the DON degradation rate data after sample storage.

[0088] Table 1. Test results of each embodiment and comparative example.

[0089] As can be seen from the test data in Table 1: Embodiment 1 of the present invention 9. Analysis of the core-shell structure with dual protection of "polyphenol crosslinking agent + metal ion source + pH-responsive coating material" is as follows: The enzyme activity retention rate after simulated granulation was higher than 88%; The enzyme release rate of simulated gastric juice was controlled at 2.7% over 2 hours. 4.2%, the active ingredients are almost not leaked prematurely in the stomach environment; The enzyme release rate in simulated intestinal fluid is ≥83.5% after 2 hours, indicating that the enzyme activity can be fully released in the intestinal environment; After 90 days of long-term storage, the DON degradation rate remained above 82.2%, demonstrating excellent processing tolerance, gastric acid resistance, and storage stability, effectively solving the shortcomings of existing technologies such as low enzyme activity retention and unstable detoxification effect.

[0090] Compared to Comparative Example 1, which lacks polyphenol cross-linking agents, and Comparative Example 2, which lacks metal ion sources, they cannot form an effective polyphenol + metal coordination cross-linking core. As a result, enzymes and coenzyme factors cannot be fixed and protected, and they are inactivated and leaked in large quantities during granulation and in the gastric acid environment. After granulation, enzyme activity drops significantly, and a large amount of enzymes are released into the gastric juice. After storage, the degradation effect of DON is very poor.

[0091] Comparative Example 3 did not have a pH-responsive coating shell, which corresponds to the existing technology of directly mixing enzymes into the feed matrix. It lacks an enteric barrier, and the enzymes are easily destroyed by the feed matrix and gastric acid. The intestinal fluid release rate and the detoxification effect after storage are significantly lower than those of the embodiments of the present invention.

[0092] Comparative Example 4 lacked both polyphenol cross-linking agents and metal ion sources, resulting in the complete absence of the cross-linking core, almost no protection for the active components, and the most severe loss of enzyme activity.

[0093] Comparative Example 5 showed that the core component allocation ratio exceeded the optimal range and cross-linking was excessive. Although gastric juice leakage was low, the release of intestinal enzymes was severely hindered, with an intestinal juice release rate of only 46.0%, and the DON degradation effect was significantly reduced.

[0094] In summary, only when the components of this application work together to construct a complete core-shell dual protection system can we simultaneously ensure heat resistance during processing, gastric inactivation, controlled release in the intestine, and long-term storage stability, thereby achieving efficient and stable biological detoxification of hydrophilic DON toxins and making it suitable for industrial application in the feed industry.

[0095] The above embodiments are merely illustrative of the technical solutions of this application and are not intended to limit it. Although this application has been described in detail with reference to the foregoing embodiments, those skilled in the art should understand that modifications can still be made to the technical solutions described in the foregoing embodiments, or equivalent substitutions can be made to some or all of the technical features therein. These modifications or substitutions do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of this application, and they should all be covered within the scope of the claims and specification of this application. In particular, as long as there is no structural conflict, the various technical features mentioned in the embodiments can be combined in any way. This application is not limited to the specific embodiments disclosed herein, but includes all technical solutions falling within the scope of the claims.

Claims

1. A mycotoxin degrading agent for animal feed, characterized in that, Its raw materials contain the following components by weight: 10-25 parts of bio-enzyme complex; 2-8 parts of coenzyme factor; 5-15 parts of polyphenol crosslinking agent; 0.5-3 parts of metal ion source; 20-40 parts of pH-responsive coating material; Dispersing agent 3-10 parts; 20-75 parts of inert filler carrier.

2. The mycotoxin degrading agent for animal feed according to claim 1, characterized in that, The bioenzyme complex includes aldehyde-ketone reductase and PQQ-dependent dehydrogenase; the mass ratio of aldehyde-ketone reductase to PQQ-dependent dehydrogenase is 2:1 to 3:

1.

3. The mycotoxin degrading agent for animal feed according to claim 1, characterized in that, The coenzyme factor includes auto-oxidized coenzyme II and pyrroloquinoline quinone; the mass ratio of the oxidized coenzyme II to pyrroloquinoline quinone is 1:4 to 1:

6.

4. The mycotoxin degrading agent for animal feed according to claim 1, characterized in that, The polyphenol crosslinking agent includes any one or a mixture of two or more of tannic acid, gallic acid, and tea polyphenols.

5. The mycotoxin degrading agent for animal feed according to claim 1, characterized in that, The metal ion source includes any one or a mixture of two or more of ferric chloride, zinc sulfate, and calcium chloride.

6. The mycotoxin degrading agent for animal feed according to claim 1, characterized in that, The pH-responsive coating material includes any one of methacrylate-ethyl acrylate copolymer, hydroxypropyl methylcellulose phthalate, and polyacrylic acid resin II.

7. A method for preparing a mycotoxin degrading agent for animal feed as described in claim 1, characterized in that, Includes the following steps: S1. Dissolve the biological enzyme complex and coenzyme factor in a buffer solution, add a polyphenol cross-linking agent, stir and mix evenly to obtain an initial mixture for later use; S2. Add metal ion source solution dropwise to the initial mixture in step S1, while controlling the reaction temperature at 20-35℃ and the reaction time at 1-3 hours. After the initial mixture forms a precipitate, collect it by centrifugation to obtain the kernel precursor for later use. S3. Take the core precursor obtained in step S2 and put it into a fluidized bed. Spray the pH-responsive coating material solution continuously through an atomizing nozzle to coat the surface of the core precursor particles to obtain pre-coated microcapsules for later use. The fluidized bed inlet temperature is 50-70℃, the outlet temperature is 35-45℃, and the fluidized bed temperature is not higher than 42℃. S4. Take the pre-coated microcapsules from step S3, and dry mix them with the dispersant and inert filler carrier to obtain the finished product of mycotoxin degrading agent for animal feed.

8. The method for preparing the mycotoxin degrading agent for animal feed according to claim 7, characterized in that, The pH value of the buffer solution in step S1 is 6.8-7.5; the stirring rate is 200-450 rpm; and the stirring time is 20-75 minutes.

9. The method for preparing the mycotoxin degrading agent for animal feed according to claim 7, characterized in that, The mixing speed of the dry mix in step S4 is 20-50 rpm; the mixing time is 15-30 minutes.

10. The use of a mycotoxin degrading agent for animal feed as described in any one of claims 1-6 in the preparation of animal feed.

Citation Information

Patent Citations

  • Means and methods to detoxify mycotoxins

    US20230380451A1